Aflac (NYSE:AFL – Get Free Report) was upgraded by equities researchers at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Friday.
Several other research firms have also recently issued reports on AFL. Truist Financial lifted their price objective on shares of Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a research report on Friday, November 1st. BMO Capital Markets initiated coverage on shares of Aflac in a report on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 target price for the company. Barclays decreased their price target on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, February 7th. Wells Fargo & Company boosted their target price on shares of Aflac from $103.00 to $104.00 and gave the stock an “equal weight” rating in a report on Tuesday, January 14th. Finally, Piper Sandler lowered their price target on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a report on Friday, February 7th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, Aflac currently has an average rating of “Hold” and a consensus price target of $103.00.
Read Our Latest Analysis on AFL
Aflac Trading Up 1.1 %
Aflac (NYSE:AFL – Get Free Report) last announced its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. Analysts expect that Aflac will post 6.95 EPS for the current year.
Insiders Place Their Bets
In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the business’s stock in a transaction that occurred on Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the sale, the executive vice president now owns 222,618 shares of the company’s stock, valued at $23,018,701.20. The trade was a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.90% of the stock is currently owned by corporate insiders.
Institutional Trading of Aflac
A number of institutional investors have recently bought and sold shares of the business. Franklin Resources Inc. raised its holdings in shares of Aflac by 75.2% in the third quarter. Franklin Resources Inc. now owns 776,131 shares of the financial services provider’s stock valued at $88,533,000 after buying an additional 333,083 shares during the last quarter. Aptus Capital Advisors LLC lifted its position in Aflac by 79.7% during the 3rd quarter. Aptus Capital Advisors LLC now owns 27,354 shares of the financial services provider’s stock worth $3,058,000 after acquiring an additional 12,131 shares during the period. Transamerica Financial Advisors Inc. purchased a new stake in shares of Aflac during the third quarter worth approximately $979,000. FMR LLC lifted its holdings in shares of Aflac by 4.0% during the third quarter. FMR LLC now owns 1,202,104 shares of the financial services provider’s stock worth $134,395,000 after purchasing an additional 45,745 shares during the period. Finally, Willis Investment Counsel lifted its holdings in shares of Aflac by 1.2% during the fourth quarter. Willis Investment Counsel now owns 273,466 shares of the financial services provider’s stock worth $28,287,000 after purchasing an additional 3,357 shares during the period. 67.44% of the stock is owned by hedge funds and other institutional investors.
About Aflac
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
See Also
- Five stocks we like better than Aflac
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- 3 Monster Growth Stocks to Buy Now
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.